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Pure red cell aplasia is characterized as a normocytic anemia associated with retic-
ulocytopenia and the absence of erythroblasts in the bone marrow. Pure red cell aplasia 
can be induced by various causes such as thymoma, connective tissue disease, viral in-
fection, lymphoma, and adverse drug reactions. There have been only a few reports of 
pure red cell aplasia associated with acute viral hepatitis A. In Korea, no case of pure 
red cell aplasia caused by acute hepatitis A has yet been reported. We recently experi-
enced a case of acute viral hepatitis A complicated by pure red cell aplasia. The patient 
was successfully treated with corticosteroids. Here we report this case and review the 
literature.
Key Words: Red-cell aplasia; Hepatitis A; Acute Kidney injury
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial 
License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, 
distribution, and reproduction in any medium, provided the original work is properly cited.
Article History:
received 17 February, 2011
accepted 9 March, 2011
Corresponding Author:
Suk Joong Oh
Division of Hemato-Oncology, 
Department of Internal Medicine, 
Kangbuk Samsung Medical Center, 
Sunggyunkwan University College of 
Medicine, 108 Pyoung-dong, 





　Pure red cell aplasia (PRCA) is a disorder that was first 
described in 1922 and that is characterized as a normocytic 
anemia associated with the absence of erythroblasts in the 
bone marrow. PRCA can be induced by various causes.
1 
However, only a few cases of PRCA associated with hep-
atitis A have been reported.
2-6 In Korea, there have been 
several reports of PRCA associated with thymoma, lym-
phoma, SLE, Hashimoto’s disease, parvovirus, and ad-
verse drug reactions. However, no case of PRCA caused by 
acute hepatitis A has yet been reported. In this report, we 
describe a case of PRCA with acute hepatitis A and review 
the literature.
CASE REPORT
　A 36-year-old male was admitted with a 3-day history of 
fever, jaundice, and vomiting. His medical history was 
unremarkable. On admission, he was alert and oriented. 
His vital signs were as follows: blood pressure, 120/90 
mmHg; heart rate, 88 beats/min; respiratory rate, 18/min; 
and body temperature, 37.1
oC. He had obvious jaundice 
and icteric sclera. The conjunctiva was not anemic. The liv-
er and spleen were not palpable. His hemoglobin concen-
tration was 17.1 g/dL, his red cell count was 5.74×10
6/µL, 
his white blood cell count was 5,000/µL, and his platelet 
count was 114,000/µL. Blood chemistry analyses revealed 
a total bilirubin level of 3.8 mg/dL; direct bilirubin, 2.39 
mg/dL; AST, 7736 IU/L; ALT, 3558 IU/L; LDH, 14,407 
IU/L; albumin, 3.8 g/dL; prothrombin time, 18.6 s (10.1- 
12.4 s); BUN, 50.9 mg/dL; and Cr, 5.7 mg/dL. 
　The test for hepatitis A virus IgM antigen was positive. 
Tests for hepatitis B surface antigen, and IgM anti-hep-
atitis B core, and anti-hepatitis C virus antibody were all 
negative. Tests for human immunodeficiency virus anti-
body and Epstein-Barr virus VCA IgM antibody were neg-
ative and parvovirus was undetectable by polymerase 
chain reaction. Tests for anti-nuclear antibody and rheu-
matoid arthritis factor were negative. C3 was 86.6 mg/dL, 
C4 was 53 mg/dL, IgG was 746 mg/dL, IgA was 442 mg/dL, 
and IgM was 469 mg/dL. Direct Coombs' test was positive 
and haptoglobin decreased to 3.5 mg/dL. The results of a 
chest X-ray, abdominal ultrasonography, and duodeno-
scopy were unremarkable. 
　He received hemodialysis treatment owing to acute re-
nal failure three times a week from day 2. On day 4, he was 
diagnosed with hepatitis A and treated with fluid therapy. 
On admission, there was no sign of anemia, but his hemo-
globin level had gradually decreased. No sign of gastro-
intestinal bleeding was observed. On day 23, his hemoglo-
bin level had dropped to 4.8 g/dL and his reticulocyte count 
had significantly decreased to 0.13%. The peripheral blood 
smear showed microcytic, normochromic anemia with 52
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FIG. 1. Bone marrow biopsy section showing normocelluar marrow
with marked erythroid hypoplasia (×200, H&E stain).
FIG. 2. Bone marrow aspirates showing a paucity of erythroid precursors with normal granulocytes and megakaryocytes. (A) (×200,
Wright-Geimsa stain). (B) (×400, Wright-Geimsa stain) arrow: basophilic normoblast.
FIG. 3. The time course of the hemoglobin, reticulocyte count, and
serum creatinine.
anisopoikilocytosis. A total of 6 U of red cells were admini-
stered for 3 days. Bone marrow biopsy and aspiration were 
performed on day 25. The bone marrow biopsy showed 50% 
cellularity and the myeloid:erythroid ratio was 16.1:1. 
Marked hypoplastic erythropoiesis was observed (Fig. 1). 
A paucity of erythroid precursors was noted, although 
granulopoiesis was normal in number and maturation. 
Megakaryocytes were normally observed (Fig. 2). Differen-
tial erythroid cell counts of aspirates were as follows: pro-
normoblast, 1.4%; basophilic normoblast, 2.4%; polychro-
matic normoblast, 0.0%; and orthochromatic normoblast, 
0.0%.
　As a result of these findings, he was diagnosed with pure 
red cell aplasia associated with acute hepatitis A. He began 
treatment with intravenous methylprednisolone (1 mg/kg/ 
day) daily at day 29. After the steroid therapy, his hemoglo-
bin level and renal function began to improve steadily. 
Hemodialysis was stopped on day 34, and the hemoglobin 
level had increased to 8.3 g/dL on discharge. Methylpredni-
solone was tapered by 10 mg every week until discharge. 
One month after discharge, the prednisolone dose was ta-
pered to 10 mg in the outpatient clinic. On day 48 after dis-
charge, prednisolone treatment was stopped, because the 
hemoglobin level had improved to 13.9 g/dL and the Cr level 
had decreased to 1.3 mg/dL (Fig. 3).
DISCUSSION
　PRCA results in an anemia associated with severe retic-
ulocytopenia and the absence of marrow erythroid pre-
cursor cells.
1 Innate PRCA is known as Blackfan-Diamond 
anemia, and is usually diagnosed among infants less than 
1 year of age. In adults, PRCA usually occurs as an acquired 
disease, mainly due to thymoma, connective tissue disease, 
viral infection, lymphoma, and adverse drug reactions.
1
　In the present case, while the patient was being treated 
with fluid therapy and hemodialysis for hepatitis A with 53
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acute renal failure, his hemoglobin level gradually de-
creased. No signs of gastrointestinal bleeding were ob-
served and no evidence of thymoma was apparent in the 
chest X-ray. Results were negative for human immuno-
deficiency virus antibody, Epstein-Barr virus VCA IgM an-
tibody, viral hepatitis B antibody, viral hepatitis C anti-
body, anti-nuclear antibody, parvovirus PCR, and rheu-
matoid arthritis factor. There were no suspicious findings 
for lymphoma in the peripheral blood smear or bone ma-
rrow. His medical history was unremarkable. Bone ma-
rrow examination showed marked erythroid hypoplasia 
with normal granulocytes and megakaryocytes. As a re-
sult, he was diagnosed with PRCA caused by acute hep-
atitis A.
　Globally, cases of acute hepatitis A associated with 
PRCA are very rare. In all of the cases reported to date, tran-
sient, severe anemia appeared after the acute phase of the 
hepatitis had passed and disappeared within a short period 
after blood transfusion or corticosteroid therapy. The clin-
ical course of PRCA with hepatitis A and the prognosis of 
the patients were good.
2-6 
　The mechanism of PRCA seen in many cases of viral hep-
atitis is poorly understood. Bone marrow and liver contain 
components of the reticuloendothelial system and may, 
therefore, be adversely affected by similar agents. Previ-
ously known main mechanisms are viral-induced auto-
immune response and direct viral infection of bone marrow 
progenitor cells.
1 The autoimmune response can directly 
cause a cytolytic reaction to bone marrow progenitor cells 
by T-cells, natural killer cells, or complement binding with 
antibody and can damage bone marrow stromal cells.
1
　Idiopathic PRCA can be initially treated with cortico-
steroids and blood transfusion. Generally, the recovery pe-
riod is about 1 month.
7 In a study of 27 PRCA patients using 
corticosteroids for 2 to 5 weeks, remission occurred within 
4 weeks in 40% of cases, and a cure rate of 37% was repor-
ted.
8 Case studies of PRCA with acute viral hepatitis are 
rare; cases of treatment with corticosteroids and blood 
transfusion have been reported.
2-6
　In corticosteroid-resistant cases, PRCA can be treated 
with cyclosporin A or cyclophosphamide. A study of 43 pa-
tients treated with cyclosporin A showed an overall re-
sponse of 65%.
9 One study reported that the duration of re-
mission induced by cyclophosphamide seemed to be pro-
longed compared with that induced by corticosteroid.
8 In 
addition, several studies reported that antithymocyte 
globulin, alemtuzumab, and rituximab are useful in the 
treatment of refractory PRCA.
7 
　In summary, we have reported the first case of PRCA as-
sociated with acute hepatitis A in Korea. The case was 
treated with corticosteroids and transfusion, reflecting the 
previous literature. The patient showed an early response 
to corticosteroids and successfully achieved remission af-
ter 2 months of treatment. 
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